Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FECBUD trial of budesonide or placebo pretreatment before fecal microbiota transplantation in active ulcerative colitis
NL-OMON49003Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- May 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Randomised, double-blind trial of budesonide and allogeneic fecal microbiota in autoimmune colitis, sponsored by Leiden University Medical Center. Started May 2019; status: active, not recruiting.
02
Drugs
budesonideallogeneic fecal microbiota
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on NL-OMON49003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49003.